Pfizer wins bidding war for obesity drug startup
US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival Novo Nordisk.
US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival Novo Nordisk.
China is resuming exports of chips critical to making European cars, potentially setting the stage for the end of a row between Beijing and the Netherlands.
The pain of the US government shutdown deepened as flight cancellations piled up and politicians exchanged blame over the funding stalemate.
Governor Janet Mills, who previously raised $200,000 from companies and corporate PACs, is running against leftist insurgent Graham Platner, in Maine's Democratic primary.
An obscure election galvanizes national power battles, a worker takes on corporate exploitation, consumers’ favorite energy program survives Trump, and electoral wins reverberate nationwide.
Whether or not Congress extends the Affordable Care Act’s enhanced premium tax credits, health care giants are poised to extract new profits from patient pain.
There is no “too big to fail” in the tech industry. In fact, failure is one of the key characteristics of Silicon Valley.
The shutdown has reignited worries about the use of state-ordered internet blackouts on the continent during elections or unrest.